UnitedHealth Group Incorporated [NYSE: UNH] traded at a high on 10/16/20, posting a 1.64 gain after which it closed the day’ session at $329.90. The company report on October 15, 2020 that United Health Foundation Pledges $2.5 Million to Support Breast Cancer Screenings for Michigan Residents.
Three-year partnership with the Michigan Primary Care Association will establish pilot program for breast cancer genetic testing and screening.
The United Health Foundation has committed $2.5 million to the Michigan Primary Care Association (MPCA) to support increased breast cancer screening and genetic testing for high-risk women, men and their families. The partnership will establish a breast cancer genetic testing and screening pilot program at five Michigan community health centers to increase patient education and testing rates, and enhance transitions of care through improved technology, community partnerships and data analysis.
The results of the trading session contributed to over 3289070 shares changing hands. Over the past one week, the price volatility of UnitedHealth Group Incorporated stands at 2.43% while the volatility over the past one month is 2.34%.
The market cap for UNH stock reached $308.45 billion, with 949.00 million shares outstanding and 944.73 million shares in the current float. Compared to the average trading volume of 2.72M shares, UNH reached a trading volume of 3289070 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about UnitedHealth Group Incorporated [UNH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $357.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
SVB Leerink have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 01, 2020. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on June 05, 2020, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $308, while Deutsche Bank analysts kept a Buy rating on UNH stock.
The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 7.82, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.22. The Price to Book ratio for the last quarter was 4.92, with the Price to Cash per share for the same quarter was set at 23.88. Price to Free Cash Flow for UNH in the course of the last twelve months was 25.50.
How has UNH stock performed recently?
UnitedHealth Group Incorporated [UNH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.63. With this latest performance, UNH shares gained by 8.17% in over the last four-week period, additionally plugging by 16.93% over the last 6 months – not to mention a rise of 35.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 62.59, with the RSI for the last a single of trading hit 65.53, and the three-weeks RSI is set at 60.66 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 313.17, while it was recorded at 327.54 for the last single week of trading, and 291.74 for the last 200 days.
UnitedHealth Group Incorporated [UNH]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.13. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +5.71.
Return on Total Capital for UNH is now 20.09, given the latest momentum, and Return on Invested Capital for the company is 15.05. Return on Equity for this stock inclined to 25.32, with Return on Assets sitting at 8.36. When it comes to the capital structure of this company, UnitedHealth Group Incorporated [UNH] has a Total Debt to Total Equity ratio set at 77.47. Additionally, UNH Total Debt to Total Capital is recorded at 43.65, with Total Debt to Total Assets ending up at 25.25. Long-Term Debt to Equity for the company is recorded at 69.36, with the Long-Term Debt to Total Capital now at 39.08.
Reflecting on the efficiency of the workforce at the company, UnitedHealth Group Incorporated [UNH] managed to generate an average of $42,582 per employee.
Earnings analysis for UnitedHealth Group Incorporated [UNH]
With the latest financial reports released by the company, UnitedHealth Group Incorporated posted 3.9/share EPS, while the average EPS was predicted by analysts to be reported at 3.77/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 12.69%.
Insider trade positions for UnitedHealth Group Incorporated [UNH]
There are presently around $275,118 million, or 89.60% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 80,727,140, which is approximately 7.532% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 73,347,462 shares of the stock with an approximate value of $24.2 billion in UNH stocks shares; and FMR LLC, currently with $18.22 billion in UNH stock with ownership of nearly -0.055% of the company’s market capitalization.
Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 1,118 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 35,852,996 shares. Additionally, 943 investors decreased positions by around 34,817,910 shares, while 241 investors held positions by with 763,274,031 shares. The mentioned changes placed institutional holdings at 833,944,937 shares, according to the latest SEC report filing. UNH stock had 187 new institutional investments in for a total of 2,474,055 shares, while 95 institutional investors sold positions of 1,383,076 shares during the same period.